An experimental pill developed by Merck to treat COVID-19 has done so well in late-stage clinical trials – reducing risk of hospitalization and death by nearly half – that an independent board of experts recommended stopping the trial early. Continue reading “Experimental Pill To Treat COVID-19 Cuts Risk Of Hospitalizations & Death In Half”